Celldex Therapeutics (CLDX) Net Margin Growth (1y) (2011 - 2026)
Celldex Therapeutics (CLDX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | -56.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.49 Mn |
| Dec 31, 2025 | -8.66 Mn |
| Jun 30, 2025 | -736,024.00 |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | -296,266.00 |
| Sep 30, 2024 | 120,209.00 |
| Jun 30, 2024 | 994,652.00 |
| Mar 31, 2024 | -1.80 Mn |
| Dec 31, 2023 | 59,378.00 |
| Sep 30, 2023 | 405,875.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 439,024.00 |
| Sep 30, 2022 | 678,648.00 |
| Jun 30, 2022 | -2.17 Mn |
| Mar 31, 2022 | -1.08 Mn |
| Dec 31, 2021 | -545,389.00 |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | 428,987.00 |
| Mar 31, 2021 | -171,292.00 |